Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure–Response

Author:

Balevic Stephen J.12,Niu Jing3,Chen Jianmeng3,Green Dionna4,McMahon Ann4,Hornik Christoph P.1,Schanberg Laura E.12,Glaser Rachel5,Gonzalez Daniel6,Burckart Gilbert J.3

Affiliation:

1. Duke Clinical Research Institute Durham North Carolina USA

2. Department of Pediatrics Duke University Durham North Carolina USA

3. Office of Clinical Pharmacology Center for Drug Evaluation and Research (CDER) United States Food and Drug Administration (FDA) Silver Spring Maryland USA

4. Office of Pediatric Therapeutics Office of the Commissioner United States Food and Drug Administration (FDA) Silver Spring Maryland USA

5. Division of Rheumatology and Transplant Medicine Office of Immunology and Inflammation Office of New Drugs CDER, FDA Silver Spring Maryland USA

6. Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference51 articles.

1. Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs

2. Product Label.Belimumab Injection. GlaxoSmithKline LLC.: Philadelphia PA;2021.

3. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis

4. United States Food and Drug Administration (FDA).Pediatric science and research activities. FDA web site.https://www.fda.gov/science‐research/pediatrics/pediatric‐science‐and‐research‐activities. Updated October 15 2021. Accessed October 25 2021.

5. United States Food and Drug Administration (FDA).Guidance document: general clinical pharmacology considerations for pediatric studies for drugs and biological products. December2014. FDA web site.https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM425885.pdf. Accessed October 25 2021.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3